---
title: "Vyndamax (tafamidis) in transthyretin amyloid cardiomyopathy: Access and coverage questions"
description: "Access and coverage questions on Vyndamax (tafamidis) in transthyretin amyloid cardiomyopathy, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Access and billing, Cost and coverage, Access and support, Prior authorization, and Patient support. Questions: What is the NDC for Vyndamax? Is there a Vyndamax copay card? How much do commercially insured patients pay for Vyndamax with the copay card? Can Medicare patients use the Vyndamax copay card? 11 further questions follow. 15 questions quoted from 8 sources."
canonical: "https://www.evicenter.com/medical-information/vyndamax--transthyretin-amyloid-cardiomyopathy/access-and-coverage"
published: "2026-11-14T00:11:41-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Vyndamax (tafamidis) in transthyretin amyloid cardiomyopathy: Access and coverage questions

Manufacturer: Pfizer Inc  
Prescribing information: [Vyndaqel and Vyndamax](https://labeling.pfizer.com/ShowLabeling.aspx?id=11685)

## Access and billing

<a id="vyndamax-ndc"></a>

### What is the NDC for Vyndamax?

> “VYNDAMAX 61-mg (tafamidis) soft gelatin capsules are reddish brown, opaque, oblong, and printed with "VYN 61" in white and supplied in the following package configurations:
>
> VYNDAMAX Capsules
> Package Configuration	Strength	NDC
>
>
> Carton of 3 blister cards. Each blister card contains 10 capsules. (30 capsules total)
>
>
>
> 61 mg
>
>
>
> NDC 0069-8730-30”

Source: [VYNDAMAX: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=11685#:~:text=VYNDAMAX%2061%2Dmg%20%28tafamidis%29%20soft%20gelatin,NDC%200069%2D8730%2D30)

## Cost and coverage

<a id="vyndamax-copay-card"></a>

### Is there a Vyndamax copay card?

> “Co-Pay Savings Program
>
> If your patient is commercially insured and eligible, the VYNDAMAX Co-Pay Savings Program may help reduce their out-of-pocket costs to as little as $0 per month.*”

Source: [VYNDAMAX: Financial Support | VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp/financial-assistance#:~:text=Co%2DPay%20Savings%20Program,little%20as%20%240%20per%20month.%2A)

> “Limits, terms, and conditions apply. Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE <sup>®</sup>, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico. $10,000-$60,000 maximum program benefit per calendar year. The offer will be accepted only at participating pharmacies. This offer is not health insurance. No membership fees apply. Pfizer reserves the right to rescind, revoke, or amend this offer without notice.”

Source: [VYNDAMAX: Financial Support | VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp/financial-assistance#:~:text=Limits%2C%20terms%2C%20and%20conditions%20apply.,amend%20this%20offer%20without%20notice.)

<a id="vyndamax-cost"></a>

### How much do commercially insured patients pay for Vyndamax with the copay card?

> “Eligible commercially insured patients may pay as little as $0 per month through the VYNDAMAX Co-Pay Savings Program”

Source: [VYNDAMAX: How to Access VYNDAMAX® (tafamidis) for Your Patients | Safety Info, captured 2026-11-13](https://vyndamax.pfizerpro.com/access-and-support/accessing-vyndamax#:~:text=Eligible%20commercially%20insured%20patients%20may,the%20VYNDAMAX%20Co%2DPay%20Savings%20Program)

> “Limits, terms, and conditions apply. Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE <sup>®</sup>, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico. $10,000-$60,000 maximum program benefit per calendar year. The offer will be accepted only at participating pharmacies. This offer is not health insurance. No membership fees apply. Pfizer reserves the right to rescind, revoke, or amend this offer without notice.”

Source: [VYNDAMAX: Financial Support | VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp/financial-assistance#:~:text=Limits%2C%20terms%2C%20and%20conditions%20apply.,amend%20this%20offer%20without%20notice.)

<a id="vyndamax-copay-medicare"></a>

### Can Medicare patients use the Vyndamax copay card?

> “Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE <sup>®</sup>, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico.”

Source: [VYNDAMAX: Financial Support | VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp/financial-assistance#:~:text=Patients%20are%20not%20eligible%20to,Plan%20available%20in%20Puerto%20Rico.)

<a id="vyndamax-financial-assistance"></a>

### What Vyndamax financial assistance is available besides the copay card?

> “Financial Assistance Options for Patients
>
> Financial support information from resources that are wholly independent from Pfizer.”

Source: [VYNDAMAX: Financial Support | VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp/financial-assistance#:~:text=Financial%20Assistance%20Options%20for%20Patients,are%20wholly%20independent%20from%20Pfizer.)

> “Eligible patients who have been prescribed VYNDAMAX may have access to financial assistance programs. Depending on eligibility, commercially insured patients may qualify for co-pay assistance, and additional financial assistance resources may be available to help support access to treatment. Visit VynAssist to learn more about available programs and eligibility requirements.”

Source: [VYNDAMAX: How to Access VYNDAMAX® (tafamidis) for Your Patients | Safety Info, captured 2026-11-13](https://vyndamax.pfizerpro.com/access-and-support/accessing-vyndamax#:~:text=Eligible%20patients%20who%20have%20been%20prescribed%20VYNDAMAX%20may,available%20programs%20and%20eligibility%20requirements.)

> “An Access Care Manager is available to help you and your staff to understand which financial support options may be most appropriate for your patients.”

Source: [VYNDAMAX: Financial Support | VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp/financial-assistance#:~:text=An%20Access%20Care%20Manager%20is,most%20appropriate%20for%20your%20patients.)

<a id="vyndamax-insurance-coverage"></a>

### Vyndamax coverage: what share of Medicare and commercial patients can start therapy?

> “more than 90% of patients with Medicare or commercial insurance can start on therapy<sup>†</sup> after meeting standard prior authorization or formulary exception criteria.<sup>‡</sup>”

Source: [VYNDAMAX: VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp#:~:text=more%20than%2090%25%20of%20patients,prior%20authorization%20or%20formulary%20exception)

> “<sup>†</sup>Therapy=VYNDAMAX or VYNDAQEL ® (tafamidis meglumine).”

Source: [VYNDAMAX: VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp#:~:text=or%20VYNDAQEL%20%C2%AE%20%28tafamidis%20meglumine%29.)

> “MMIT formulary data are current as of 07/2025. Data on file. Pfizer Inc, New York, NY, July 2025. The information provided is not a guarantee of coverage or payment (partial or full), and is subject to change without notice. Coverage may vary by region. Please confirm coverage with each patient's plan.”

Source: [VYNDAMAX: VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp#:~:text=MMIT%20formulary%20data%20are%20current,coverage%20with%20each%20patient%27s%20plan.)

Note: The figure is the manufacturer's statement based on MMIT formulary data as of July 2025, as shown on the VynAssist HCP home page captured November 13, 2026.

<a id="vyndamax-medicare-open-enrollment"></a>

### What are the Medicare open enrollment dates for Vyndamax patients' 2027 coverage?

> “Medicare plans can change every year in terms of cost, covered medications, and in-network pharmacies. Patients may consider evaluating insurance plans to find the one that best suits their needs.
>
> Patients can visit Medicare.gov/plan-compare or call 1-800-MEDICARE (1-800-633-4227) for help with selecting a plan.”

Source: [VYNDAMAX: Medicare 2027 | VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp/medicare#:~:text=Medicare%20plans%20can%20change%20every,help%20with%20selecting%20a%20plan.)

> “Key dates for Medicare Open Enrollment
>
> OCT 15
>
> Open Enrollment begins.
> 2027 plan info published on
> Medicare.gov/plan-compare.
>
> OCT 2026
>
> DEC 7
>
> Open Enrollment ends.
> Last day for patients to
> make changes to their
> coverage for 2027.
>
> DEC 2026
>
> JAN 1*
>
> Changes to coverage
> go into effect.
>
> JAN 2027
>
> *
> For patients enrolled in a Medicare Advantage plan, additional plan changes may be made between January 1 and March 31, 2027.”

Source: [VYNDAMAX: Medicare 2027 | VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp/medicare#:~:text=Key%20dates%20for%20Medicare%20Open,1%20and%20March%2031%2C%202027.)

Note: These are general Medicare enrollment dates, shown on the VynAssist HCP Medicare 2027 page captured November 13, 2026.

## Access and support

<a id="vyndamax-free-trial"></a>

### Is there a Vyndamax free trial?

> “New patients may be eligible to receive a one-time, 30-day trial of VYNDAMAX.”

Source: [VYNDAMAX: Free Trial Program | VYNDAMAX® (tafamidis) | Safety Info, captured 2026-11-13](https://vyndamax.pfizerpro.com/access-and-support/free-trial-program#:~:text=New%20patients%20may%20be%20eligible,one%2Dtime%2C%2030%2Dday%20trial%20of%20VYNDAMAX.)

> “Download the free trial form to get your patient started:
>
> Complete the form
> Sign and date
> Fax to VYNDAMAX Free Trial Program at (800) 781-6536”

Source: [VYNDAMAX: Free Trial Program | VYNDAMAX® (tafamidis) | Safety Info, captured 2026-11-13](https://vyndamax.pfizerpro.com/access-and-support/free-trial-program#:~:text=Download%20the%20free%20trial%20form,Trial%20Program%20at%20%28800%29%20781%2D6536)

<a id="vyndamax-specialty-pharmacy"></a>

### Which specialty pharmacies dispense Vyndamax?

> “VYNDAMAX is available through a defined distribution network of Specialty Pharmacies.  
> While you may send your prescription to the dispensing Specialty Pharmacy of your choice, choosing  
> a Specialty Pharmacy aligned to the patient’s insurer may reduce barriers to patient access.”

Source: [VYNDAMAX: Prior Authorization Checklist, page 2, captured 2026-11-13](https://www.myvynassist.com/files/PPD-VDM-USA-2539-VYNDAMAX-PA-Checklist-Update.pdf#page=2)

> “Pfizer does not endorse any specific pharmacy. Other eligible institutions may also be able to dispense  
> VYNDAMAX. Please confirm preferred pharmacy with patient’s individual plan when considering treatment.”

Source: [VYNDAMAX: Prior Authorization Checklist, page 2, captured 2026-11-13](https://www.myvynassist.com/files/PPD-VDM-USA-2539-VYNDAMAX-PA-Checklist-Update.pdf#page=2)

> “CenterWell Specialty Pharmacy
> CenterWellSpecialtyPharmacy.com
> Phone: 800-486-2668
> Fax: 877-405-7940
> Monday-Friday, 8 am-11 pm ET
> Saturday, 8 am-6:30 pm ET
> CVS Specialty
> cvsspecialty.com
> Phone: 800-237-2767
> Fax: 800-323-2445
> Monday-Friday, 8 am-8 pm ET
> Walgreens Specialty Pharmacy
> WalgreensSpecialtyRx.com
> Phone: 800-516-9180
> Fax: 877-235-9807
> Monday-Friday, 8 am-5 pm ET
> Saturday, 8 am-5 pm ET
> Optum Specialty Pharmacy
> Specialty.OptumRx.com
> Phone: 855-427-4682
> Fax: 877-342-4596
> 24/7 support
> Orsini Specialty Pharmacy
> OrsiniSpecialtyPharmacy.com
> Phone: 800-410-8575
> Fax: 847-879-9551
> 24/7 support
> Accredo
> accredo.com
> Phone: 866-759-1557
> Fax: 888-302-1028 
> Monday-Friday, 8 am-8 pm ET”

Source: [VYNDAMAX: Prior Authorization Checklist, page 2, captured 2026-11-13](https://www.myvynassist.com/files/PPD-VDM-USA-2539-VYNDAMAX-PA-Checklist-Update.pdf#page=2)

> “Use your own IDN SPP if eligible, or choose from our network of distribution partners.”

Source: [VYNDAMAX: How to Access VYNDAMAX® (tafamidis) for Your Patients | Safety Info, captured 2026-11-13](https://vyndamax.pfizerpro.com/access-and-support/accessing-vyndamax#:~:text=Use%20your%20own%20IDN%20SPP,our%20network%20of%20distribution%20partners.)

Note: The pharmacy list is from the VYNDAMAX Prior Authorization Checklist (May 2026) linked from the VynAssist HCP Medicare 2027 page. The Specialty Pharmacy Flashcard (September 2026), linked from the same page, lists the same six pharmacies with the same phone and fax numbers.

<a id="vyndamax-how-to-get"></a>

### How do patients get Vyndamax after it is prescribed?

> “After VYNDAMAX is prescribed, healthcare providers submit a prior authorization and send the prescription to a specialty pharmacy. Once approved, VYNDAMAX can be shipped directly to the patient's home.”

Source: [VYNDAMAX: How to Access VYNDAMAX® (tafamidis) for Your Patients | Safety Info, captured 2026-11-13](https://vyndamax.pfizerpro.com/access-and-support/accessing-vyndamax#:~:text=After%20VYNDAMAX%20is%20prescribed%2C%20healthcare,directly%20to%20the%20patient%27s%20home.)

> “Submit Prior Authorization
> Use CoverMyMeds to submit PAs or renewals electronically—at no cost.
> Send Rx to Specialty Pharmacy
> Use your own IDN SPP if eligible, or choose from our network of distribution partners.
> VYNDAMAX shipped to patient
> Once approved, the medication is delivered directly to the patient’s home.”

Source: [VYNDAMAX: How to Access VYNDAMAX® (tafamidis) for Your Patients | Safety Info, captured 2026-11-13](https://vyndamax.pfizerpro.com/access-and-support/accessing-vyndamax#:~:text=Submit%20Prior%20Authorization,directly%20to%20the%20patient%E2%80%99s%20home.)

## Prior authorization

<a id="vyndamax-prior-authorization"></a>

### Does Vyndamax require prior authorization?

> “Prior authorization (PA) is required for VYNDAMAX<sup>®</sup> (tafamidis). The prescribing physician is responsible for preparing and 
> submitting the PA. VynAssist<sup>®</sup>, Pfizer Field Access Specialists (FAS), or sales representatives cannot assist in completing 
> or submitting PAs. As criteria vary by payer, it is important to review plan-specific requirements. A network Specialty 
> Pharmacy or a Pfizer FAS can support benefits verification and help determine PA requirements.”

Source: [VYNDAMAX: Prior Authorization Checklist, page 1, captured 2026-11-13](https://www.myvynassist.com/files/PPD-VDM-USA-2539-VYNDAMAX-PA-Checklist-Update.pdf#page=1)

> “No matter which pathway you choose, a prior authorization (PA) may be needed.†”

Source: [VYNDAMAX: Specialty Pharmacy Flashcard, page 1, captured 2026-11-13](https://www.myvynassist.com/files/VYNDAMAX_Specialty_Pharmacy_Flashcard.pdf#page=1)

> “†Please note that where a PA request is required, the physician must submit required information directly to the patient’s insurer.”

Source: [VYNDAMAX: Specialty Pharmacy Flashcard, page 1, captured 2026-11-13](https://www.myvynassist.com/files/VYNDAMAX_Specialty_Pharmacy_Flashcard.pdf#page=1)

Note: The VYNDAMAX Prior Authorization Checklist (May 2026) states that PA is required and that criteria vary by payer; the Specialty Pharmacy Flashcard (September 2026), linked from the same VynAssist page, states that a PA may be needed.

<a id="vyndamax-prior-authorization-documents"></a>

### What documentation does a Vyndamax prior authorization need?

> “Common PA requirements
> Example information that may be appropriate to provide
> AL amyloidosis exclusion 
> All three tests must be documented as 
> negative to rule out light chain amyloidosis
> Documentation that AL amyloidosis had been excluded. All of the  
> following results must be negative: 
> •    Serum protein electrophoresis with immunofixation (SPIE)  
> •    Urine protein electrophoresis with immunofixation (UPIE)
> •    Serum free light chain assay”

Source: [VYNDAMAX: Prior Authorization Checklist, page 1, captured 2026-11-13](https://www.myvynassist.com/files/PPD-VDM-USA-2539-VYNDAMAX-PA-Checklist-Update.pdf#page=1)

> “ATTR-CM diagnosis
> e.g., the diagnostic evaluation steps used to  
> determine that ATTR-CM is present”

Source: [VYNDAMAX: Prior Authorization Checklist, page 1, captured 2026-11-13](https://www.myvynassist.com/files/PPD-VDM-USA-2539-VYNDAMAX-PA-Checklist-Update.pdf#page=1)

> “Testing results
> Documentation confirming ATTR amyloid  
> deposition and cardiac involvement
> Confirmation of ATTR amyloid deposits using nuclear imaging / bone scintigraphy 
> for cardiac amyloidosis — technetium pyrophosphate scan (PYP scan), also known 
> as: bone scintigraphy, nuclear scintigraphy, cardiac scintigraphy, 99mTc-PYP,  
> 99mTc-DPD, 99mTc-HMDP
>  •   Alternative to nuclear imaging: cardiac tissue biopsy
> Cardiac imaging suggestive of amyloidosis — echocardiogram and  
> cardiac magnetic resonance imaging (MRI)
> Genetic testing for TTR mutation
> Heart failure classification
> e.g., New York Heart Association (NYHA) class
> NYHA class I – III
> Prescribed by specialist
> A cardiologist or physician who treats amyloidosis
> Sometimes required
> •   At least 1 prior hospitalization for heart failure
> •   Clinical symptoms of cardiomyopathy and heart failure”

Source: [VYNDAMAX: Prior Authorization Checklist, page 1, captured 2026-11-13](https://www.myvynassist.com/files/PPD-VDM-USA-2539-VYNDAMAX-PA-Checklist-Update.pdf#page=1)

Note: The passages are from the VYNDAMAX Prior Authorization Checklist linked from the VynAssist HCP Medicare 2027 page.

<a id="vyndamax-prior-authorization-submit"></a>

### How do you submit a Vyndamax prior authorization?

> “Use CoverMyMeds to submit PAs or renewals electronically—at no cost.”

Source: [VYNDAMAX: How to Access VYNDAMAX® (tafamidis) for Your Patients | Safety Info, captured 2026-11-13](https://vyndamax.pfizerpro.com/access-and-support/accessing-vyndamax#:~:text=Use%20CoverMyMeds%20to%20submit%20PAs%20or%20renewals%20electronically%E2%80%94at%20no%20cost.)

> “You can use CoverMyMeds®‡ to electronically submit PA requests to any health plan 
> through a no-cost online platform at www.CoverMyMeds.com or an integrated EHR system. 
> For more information, contact CoverMyMeds via live chat 
> www.CoverMyMeds.com or by calling 1-866-452-5017”

Source: [VYNDAMAX: Specialty Pharmacy Flashcard, page 1, captured 2026-11-13](https://www.myvynassist.com/files/VYNDAMAX_Specialty_Pharmacy_Flashcard.pdf#page=1)

> “VynAssist<sup>®</sup>, Pfizer Field Access Specialists (FAS), or sales representatives cannot assist in completing 
> or submitting PAs.”

Source: [VYNDAMAX: Prior Authorization Checklist, page 1, captured 2026-11-13](https://www.myvynassist.com/files/PPD-VDM-USA-2539-VYNDAMAX-PA-Checklist-Update.pdf#page=1)

> “†Please note that where a PA request is required, the physician must submit required information directly to the patient’s insurer.”

Source: [VYNDAMAX: Specialty Pharmacy Flashcard, page 1, captured 2026-11-13](https://www.myvynassist.com/files/VYNDAMAX_Specialty_Pharmacy_Flashcard.pdf#page=1)

<a id="vyndamax-prior-authorization-denial"></a>

### What if a Vyndamax prior authorization is denied?

> “- Incorrect ICD code  
> - Incomplete AL rule out
> - Inadequate imaging”

Source: [VYNDAMAX: Prior Authorization Checklist, page 1, captured 2026-11-13](https://www.myvynassist.com/files/PPD-VDM-USA-2539-VYNDAMAX-PA-Checklist-Update.pdf#page=1)

> “Letter of Appeal  
> (Click here to see example)
> Letter of Medical Necessity”

Source: [VYNDAMAX: Prior Authorization Checklist, page 1, captured 2026-11-13](https://www.myvynassist.com/files/PPD-VDM-USA-2539-VYNDAMAX-PA-Checklist-Update.pdf#page=1)

Note: The passages are the common reasons for denial and the appeal documents listed in the VYNDAMAX Prior Authorization Checklist linked from the VynAssist HCP Medicare 2027 page. The checklist also directs prescribers to contact their Pfizer Field Access Specialist (FAS) for next steps when a PA is denied.

## Patient support

<a id="vyndamax-vynassist"></a>

### What is VynAssist for Vyndamax patients?

> “VYNDAMAX offers access support through VynAssist—including dedicated Access Care Managers who guide HCPs and patients with a valid prescription through prior authorization, specialty pharmacy selection, and delivery”

Source: [VYNDAMAX: How to Access VYNDAMAX® (tafamidis) for Your Patients | Safety Info, captured 2026-11-13](https://vyndamax.pfizerpro.com/access-and-support/accessing-vyndamax#:~:text=VYNDAMAX%20offers%20access%20support%20through,specialty%20pharmacy%20selection%2C%20and%20delivery)

> “An Access Care Manager streamlines support for patients and their care teams throughout the VYNDAMAX access journey by:
>
> Serving as a single point of contact for patients and care teams
> Providing education about the insurance approval process and potential available financial assistance options, as appropriate
> Supporting access and reimbursement coordination for patients who have opted in to an Access Care Manager*”

Source: [VYNDAMAX: VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp#:~:text=An%20Access%20Care%20Manager%20streamlines,to%20an%20Access%20Care%20Manager%2A)

> “Call 1-888-863-1177 (Mon-Fri, 8 AM-7 PM ET) to connect with a VynAssist Access Care Manager”

Source: [VYNDAMAX: VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp#:~:text=Call%201%2D888%2D863%2D1177%20%28Mon%2DFri%2C%208%20AM%2D7,a%20VynAssist%20Access%20Care%20Manager)

> “<sup>*</sup>Available only for patients who opt in. Patients can opt in at myVynSupport.com.”

Source: [VYNDAMAX: VynAssist, captured 2026-11-13](https://www.myvynassist.com/hcp#:~:text=only%20for%20patients%20who%20opt%20in.%20Patients%20can%20opt%20in%20at%20myVynSupport.com.)

Note: The VYNDAMAX Prior Authorization Checklist states that VynAssist cannot assist in completing or submitting PAs; the prescribing physician is responsible for preparing and submitting the PA.

## Related pages
- [Medical information: Vyndamax (tafamidis): Transthyretin amyloid cardiomyopathy](https://www.evicenter.com/medical-information/vyndamax--transthyretin-amyloid-cardiomyopathy)
- [Indication](https://www.evicenter.com/medical-information/vyndamax--transthyretin-amyloid-cardiomyopathy/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/vyndamax--transthyretin-amyloid-cardiomyopathy/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/vyndamax--transthyretin-amyloid-cardiomyopathy/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/vyndamax--transthyretin-amyloid-cardiomyopathy/safety)
- [Specific populations](https://www.evicenter.com/medical-information/vyndamax--transthyretin-amyloid-cardiomyopathy/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/vyndamax--transthyretin-amyloid-cardiomyopathy/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/vyndamax--transthyretin-amyloid-cardiomyopathy/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/vyndamax--transthyretin-amyloid-cardiomyopathy/storage-and-supply)
- [Guidelines](https://www.evicenter.com/medical-information/vyndamax--transthyretin-amyloid-cardiomyopathy/guidelines)
